ERYTECH PHARMA - SPON ADR (ERYP) Earnings History & Surprises

NASDAQ:ERYP • US29604W1080

Current stock price

0.78 USD
0 (0%)
Last:

ERYP Earnings overview

Past quarterly earnings results for ERYTECH PHARMA - SPON ADR (ERYP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Sep 11, 2023
Period
Q1 / 2023
EPS Estimate
-€0.19
Revenue Estimate
299.88K

Last Reported

Most Recent
Release Date
May 9, 2023
Period
Q4 / 2022
EPS Reported
EPS Surprise
%
Revenue Surprise
697.48%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2022 -0.17 - 62.50% 5.694M 714K 697.48% 198.12%
Q3 2022 -0.33 - 38.98% 469K 2.55M -81.61% -69.35%
Q2 2022 -0.10 -0.52 80.74% 81.72% 954K 2.55M -62.59% -57.97%
Q1 2022 -0.44 - - 539K 2.55M -78.86% -62.57%
Q4 2021 -0.45 - 84.42% 1.91M 1.53M 24.84% 2.19%
Q3 2021 -0.55 - - 1.53M - 46.97%
Q2 2021 -0.55 - - 2.27M - 22.77%
Q1 2021 - - 1.44M - -
Q4 2020 -2.86 - - 1.869M 19.792M -90.56% -
Q3 2020 - - 1.041M - -
Q2 2020 - - 1.849M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ERYP EPS Q2Q GrowthERYP EPS Q2Q GrowthEPS Q2Q Growth Q4/21 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 50 -50

Revenue Historical Q2Q growth and Acceleration

ERYP Revenue Q2Q GrowthERYP Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 50 -50 100 150

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
118.61%
Max Revenue beat (4)
697.48%
Min Revenue beat (4)
-81.61%

Analysis

ERYP has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ERYP has beaten the revenue estimates by 118.6% on average.
ERYP Overview ERYP Technical Analysis Report ERYP Fundamental Analysis Report ERYP Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ERYTECH PHARMA - SPON ADR / ERYP Earnings FAQ

When did ERYTECH PHARMA - SPON ADR (ERYP) report earnings last quarter?

ERYTECH PHARMA - SPON ADR (ERYP) last reported earnings on 5/9/2023.

Did ERYP stock beat earnings estimates in the most recent quarter?

ERYTECH PHARMA - SPON ADR (ERYP) missed EPS estimates and beat revenue estimates in the most recent quarter.